ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 258 filers reported holding ACCELERON PHARMA INC in Q4 2020. The put-call ratio across all filers is 0.78 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,231,000 | +37.1% | 7,154 | 0.0% | 0.01% | +25.0% |
| Q2 2021 | $898,000 | -7.4% | 7,154 | 0.0% | 0.00% | -20.0% |
| Q1 2021 | $970,000 | +6.0% | 7,154 | 0.0% | 0.01% | +25.0% |
| Q4 2020 | $915,000 | +13.7% | 7,154 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $805,000 | +18.0% | 7,154 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $682,000 | +6.1% | 7,154 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $643,000 | +273.8% | 7,154 | +120.4% | 0.00% | +300.0% |
| Q4 2019 | $172,000 | +34.4% | 3,246 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $128,000 | -3.8% | 3,246 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $133,000 | -11.9% | 3,246 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $151,000 | +7.1% | 3,246 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $141,000 | -24.2% | 3,246 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $186,000 | +18.5% | 3,246 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $157,000 | +23.6% | 3,246 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $127,000 | -8.0% | 3,246 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $138,000 | – | 3,246 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 917,767 | $52,524,000 | 8.19% |
| Foresite Capital Management II, LLC | 220,268 | $12,606,000 | 4.66% |
| Foresite Capital Management III, LLC | 250,863 | $14,357,000 | 3.17% |
| Novo Holdings A/S | 650,000 | $37,200,000 | 2.95% |
| QVT Financial LP | 190,977 | $10,930,000 | 2.82% |
| Perceptive Advisors | 1,528,205 | $87,459,000 | 2.34% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,117,651 | $63,963,000 | 2.29% |
| Asymmetry Capital Management, L.P. | 39,912 | $2,284,000 | 2.11% |
| SECTORAL ASSET MANAGEMENT INC | 298,726 | $17,096,000 | 1.82% |
| Stanley-Laman Group, Ltd. | 125,020 | $7,155,000 | 1.76% |